Rate My Professor Diana Learoyd

Trained at RNSH in Sydney, Learoyd has served as a staff specialist in endocrinology there since 1992 and was appointed clinical academic consultant at the University of Sydney and RNSH in 1998, continuing until 2020. Hospital roles included Director of Clinical Training and co-Director of Physician Training. She established the RNSH Endocrine Tumour Database with a NSW Cancer Institute grant, contributed to Australia’s first thyroid cancer targeted therapy clinical trials, and initiated Sydney-wide thyroid cancer case discussion evenings. Her clinical practice covers thyroid cancer, general endocrinology, menopause, and osteoporosis. University appointments featured Postgraduate Coordinator for the Department of Medicine, MD student research project coordinator, and Endocrine Syllabus Designer for the Masters of Internal Medicine. Research interests encompass thyroid cancer, neuroendocrine tumours, and genetic endocrine diseases. Key publications include "Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Locally Advanced Papillary Thyroid Cancer" (2025), "Suppurative thyroiditis: Systematic review and clinical guidance" (2021), "Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer" (2010), and "Increasing incidence of thyroid cancer is due to overdiagnosis" (2008). A long-term member of the Endocrine Society of Australia, she served as President (2009-2010), on Federal Council (2018-2022), and received Life Membership in 2025.